Reprogramming Daptomycin and A54145 Biosynthesis to Produce Novel Lipopeptide Antibiotics

Enzyme Technologies: Metagenomics, Evolution, Biocatalysis, and Biosynthesis

Volumn , Issue , 2011, Pages 285-308

  Baltz, Richard H ^a   Nguyen, Kien T ^a   Alexander, Dylan C ^a  

^a CUBIST PHARMACEUTICALS INC   (United States)

Author keywords

Antibacterial activities of novel lipopeptides generated by combinatorial biosynthesis; Biosynthesis of A54145 A54145 biosynthetic genes, cloned in cosmids and sequenced; Reprogramming daptomycin and A54145 biosynthesis and novel lipopeptide antibiotics, cyclic acidic lipodepsipeptide antibiotic for skin and skin structure infection treatment

Indexed keywords

EID: 84886971491     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470627303.ch9     Document Type: Chapter

References (54)

1. RD Arbeit, D Maki, FP Tally, E Campanaro, BI Eisenstein. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis 38:1673-1681, 2004.
2. VG Fowler, HW Boucher, GR Corey, E Abrutyn, AW Karchmer, ME Rupp, DP Levine, HF Chambers, FP Tally, GA Vigliani, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355:653-655, 2006.
3. RH Baltz. Daptomycin: mechanisms of action and resistance, and biosynthetic engineering. Curr Opin Chem Biol 13:144-151, 2009.
4. PE Pertel, P Bernardo, C Fogerty, P Matthews, R Northland, M Benvenuto, GM Thorne, SA Luperchio, RD Arbeit, J Alder. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia. Clin Infect Dis 46:1142-1151, 2008.
5. KE Piper, JM Steckelberg, R Patel. In vitro activity of daptomycin against clinical isolates of gram-positive bacteria. J Infect Chemother 11:207-209, 2005.
6. JM Streit, JN Steenbergen, GM Thorne, J Alder, RN Jones. Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis. J Antimicrob Chemother 55:574-578, 2005.
7. JA Silverman, LI Morton, AD Vanpraagh, T Li, J Alder. Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact. J Infect Dis 191:2149-2152, 2005.
8. LD Boeck, HR Papiska, RW Wetzel, JS Mynderse, DS Fukuda, FP Mertz, DM Berry. A54145, a new lipopeptide antibiotic complex: discovery, taxonomy, fermentation and HPLC. J Antibiot 43:587-593, 1990.
9. RH Baltz, P Brian, V Miao, SK Wrigley. Combinatorial biosynthesis of lipopeptide antibiotics in Streptomyces roseosporus. J Ind Microbiol Biotechnol 33:66-74, 2006.
10. RH Baltz. Biosynthesis and genetic engineering of lipopeptides in Streptomyces roseosporus. Methods Enzymol 458:511-531, 2009.
11. V Miao, R Brost, J Chapple, M-F Cöeffet-LeGal, RH Baltz. The lipopeptide antibiotic A54145 biosynthetic gene cluster from Streptomyces fradiae. J Ind Microbiol Biotechnol 33:129-140, 2006.
12. FT Counter, NE Allen, DS Fukuda, JN Hobbs, J Ott, PW Ensminger, JS Mynderse, DA Preston, CY Wu. A54145, a new lipopeptide antibiotic complex: microbiological evaluation. J Antibiot 43:616-622, 1990.
13. RH Baltz. Biosynthesis and genetic engineering of lipopeptide antibiotics related to daptomycin. Curr Top Med Chem 8:618-638, 2008.
14. RH Baltz, V Miao, SK Wrigley. Natural products to drugs: daptomycin and related lipopeptide antibiotics. Nat Prod Rep 22:717-741, 2005.
15. M Strieker, MA Marahiel. The structural diversity of acidic lipopeptide antibiotics. ChemBioChem 10:607-616, 2009.
16. RH Baltz, KT Nguyen, DC Alexander. Genetic engineering of acidic lipopeptide antibiotics. In: RH Baltz, J Davies, AL Demain, eds. Manual of Industrial Microbiology and Biotechnology, 3rd ed. Washington, DC: ASM Press, 2010, pp 391-410.
17. DC Alexander, J Rock, X He, P Brian, V Miao, RH Baltz. Development of a genetic system for lipopeptide combinatorial biosynthesis in Streptomyces fradiae and heterologous expression of the A54145 biosynthetic gene cluster. Appl Environ Microbiol 2010. In preparation.
18. DC Alexander, J Rock, J-Q Gu, C Mascio, M Chu, P Brian, RH Baltz. Engineered production of novel lipopeptide antibiotics related to A54145 by Streptomyces fradiae mutants blocked in biosynthesis of modified amino acids and assignment of functions for lptI, lptK and lptL genes. Antimicrob Agents Chemother 2010. In preparation.
19. DC Alexander, J Rock, C Mascio, C Li, A Van Praagh, L Mortin, J-Q Gu, M Chu, JA Silverman, P Brian, RH Baltz. Production of a potent lipopeptide antibiotic related to A54145 and daptomycin by molecular engineering in Streptomyces fradiae. Chem Biol 2010. In preparation.
20. KT Nguyen, X He, D Alexander, C Li, J-Q Gu, C Mascio, A Van Praagh, L Mortin, M Chu, J Silverman, et al. Genetically engineered hybrid lipopeptide antibiotics related to A54145 and daptomycin with improved properties. Antimicrob Agents Chemother 54:1404-1413, 2010.
21. V Miao, M-F Cöeffet-LeGal, P Brian, R Brost, J Penn, A Whiting, S Martin, R Ford, I Parr, M Bouchard, et al. Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry. Microbiology 151:1507-1523, 2005.
22. V Miao, M-F Cöeffet-LeGal, K Nguyen, P Brian, J Penn, A Whiting, J Steele, D Kau, S Martin, R Ford, et al. Genetic engineering in Streptomyces roseosporus to produce hybrid lipopeptide antibiotics. Chem Biol 13:269-276, 2006.
23. KT Nguyen, D Kau, J-Q Gu, P Brian, SW Wrigley, RH Baltz, V Miao. Identification of a glutamic acid 3-methyltransferase gene by functional analysis of an accessory gene locus important for daptomycin biosynthesis in Streptomyces roseosporus. Mol Microbiol 61:1294-1307, 2006.
24. K Nguyen, D Ritz, J-Q Gu, D Alexander, M Chu, V Miao, P Brian, RH Baltz. Combinatorial biosynthesis of lipopeptide antibiotics related to daptomycin. Proc Natl Acad Sci USA 103:17462-17467, 2006.
25. J-Q Gu, KT Nguyen, C Gandhi, V Rajgarhia, RH Baltz, P Brian, M Chu. Structural characterization of daptomycin analogues A21978C1-3(D-Asn11) produced by a recombinant Streptomycies roseosporus strain. J Nat Prod 70:233-240, 2007.
26. FM Huber, RL Pieper, AJ Tietz. The formation of daptomycin by supplying decanoic acid to Streptomyces roseosporus cultures producing the antibiotic complex A21978C. J Biotechnol 7:283-292, 1988.
27. MA McHenney, TJ Hosted, BS Dehoff, PR Rosteck, RH Baltz. Molecular cloning and physical mapping of the daptomycin gene cluster from Streptomyces roseosporus. J Bacteriol 180:143-151, 1998.
28. M-F Cöeffet-Le Gal, L Thurson, P Rich, V Miao, RH Baltz. Complementation of daptomycin dptA and dptD deletion mutations in-trans and production of hybrid lipopeptide antibiotics. Microbiology 152:2993-3001, 2006.
29. K-H Rhee, J Davies. Transcription analysis of daptomycin biosynthesis genes in Streptomyces roseosporus. J Microbiol Biotechnol 16:1841-1848, 2006.
30. J Penn, A Whiting, SK Wrigley, M Latif, T Gibson, CJ Silva, X Li, V Miao, P Brian, RH Baltz. Heterologous production of daptomycin in Streptomyces lividans. J Ind Microbiol Biotechnol 33:121-128, 2006.
31. MA Fischbach, CT Walsh. Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: logic, machinery, and mechanisms. Chem Rev 106:3468- 3496, 2006.
32. C Rausch, I Hoof, T Weber, W Wohlleben, DH Huson. Phylogenetic analysis of condensation domains on NRPS sheds light on their functional evolution. BMC Evol Biol 7:78, 2007.
33. M Wittmann, U Linne, V Pohlmann, M Marahiel. Role of DptE and DptF in the lipidation reaction of daptomycin. FEBS J 275:5343-5354, 2008.
34. C Mahlert, F Kopp, J Thirlway, J Micklefield, MA Marahiel. Stereospecific enzymatic transformation of α-ketoglutarate to (2S,3R)-3-methyl glutamate during acidic lipopeptide biosynthesis. J Am Chem Soc 129:12011-12018, 2007.
35. P Wessels, H von D̈ohren, H Kleinkauf. Biosynthesis of acylpeptidolactones of the daptomycin type: a comparative analysis of peptide synthetases forming A21978C and A54145. Eur J Biochem 242:665-673, 1996.
36. M Strieker, F Kopp, C Mahlert, L-O Essen, M Marahiel. Mechanistic and structural basis of stereospecific Cβ-hydroxylation in calcium-dependent antibiotic, a daptomycin-type lipopepitde. ACS Chem Biol 2: 187-196, 2007.
37. S Doekel, M-F Cöeffet-Le Gal, J-Q Gu, M Chu, RH Baltz, P Brian., Non-ribosomal peptide synthetase module fusions to produce derivatives in Streptomyces roseosporus. Microbiology 154:2872-2880, 2008.
38. Z Zhou, JR Lai, CT Walsh. Interdomain communication between the thiolation and thioesterase domains of EntF explored by combinatorial mutagenesis and selection. Chem Biol 13:869-879, 2006.
39. DP Frueh, H Arthanari, A Koglin, DA Vosburg, AE Bennett, CT Walsh, G Wagner. Dynamic thiolation-thioesterase structure of a non-ribosomal peptide synthetase. Nature 454:903-906, 2008.
40. A Tanovic, SS Samel, L-O Essen, MA Marahiel. Crystal structure of the termination module of a nonribosomal peptide synthetase. Science 321:659-663, 2008.
41. LD Boeck, RW Wetzel. A54145, a new lipopeptide antibiotic complex: factor control through precursor directed biosynthesis. J Antibiot 43:607-615, 1990.
42. RH Baltz, MA McHenney, TJ Hosted. Genetics of lipopeptide antibiotic biosynthesis in Streptomyces fradiae A54145 and Streptomyces roseosporus A21978. Dev Ind Microbiol 34:93-99, 1997.
43. MA Gregory, R Till, MCM Smith. Integration site for Streptomyces phage φBT1 and development of site-specific integrating vectors. J Bacteriol 185:5320-5323, 2003.
44. RH Baltz. Molecular engineering approaches to peptide, polyketide and other antibiotics. Nat Biotechnol 24:1533-1540, 2006.
45. RH Baltz. Combinatorial biosynthesis of novel antibiotics and other secondary metabolites in actinomycetes. SIM News 56:148-160, 2006.
46. T Stachelhaus, HD Mootz, MA Marahiel. The specificity code of adenylation domains in nonibosomal peptide synthetases. Chem Biol 6:493-505, 1999.
47. GL Challis, J Ravel, CA Townsend. Predictive, structure-based model of amino acid recognition by nonribosomal peptide synthetase adenylation domains. Chem Biol 7:211-224, 2000.
48. SA Sieber, MA Marahiel. Molecular mechanisms underlying nonribosomal peptide synthesis: approaches to new antibiotics. Chem Rev 105:715-738, 2005.
49. MA Marahiel, L-O Essen. Nonribosomal peptide synthetases: mechanistic and structural aspects of essential domains. Methods Enzymol 458:337-351, 2009.
50. A Koglin, MR Mofid, F L̈ohr, B Scḧafer, VV Rogov, M-M Blum, T Mittag, MA Marahiel, F Bernhard, V D̈otsch. Conformational switches modulate protein interactions in peptide antibiotic synthetases. Science 312:273-276, 2006.
51. SA Samel, G Schoenafinger, TA Knappe, MA Marahiel. Structural and functional insights into a peptide bond-forming bidomain from a nonribosomal peptide synthetase. Structure 15:781-792, 2007.
52. J Gr̈unewald, SA Sieber, MA Marahiel. Chemo- and regioselective cyclization triggered by the N-terminal fatty acid chain length: the recombinant cyclase of the calcium-dependent antibiotic from Streptomyces coelicolor. Biochemistry 43:2915-2925, 2004.
53. F Kopp, J Gr̈unewald, C Mahlert, MA Marahiel. Chemoenzymatic design of acidic lipopeptide hybrids: new insights into the structure-activity relationship of daptomycin and A54145. Biochemistry 45:10474-10481, 2006.
54. D Alexander, J Davies, V Miao, RH Baltz. Abstracts of the Joint 8th Symposium on Genetics and Molecular Biology of Industrial Microorganisms (GMBIM), and 8th International Conference on the Biotechnology of Microbial Products (BMP), San Diego, CA, Nov 14-18, 2004.